[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-03", "acceptance_datetime": "2025-11-03T12:14:15Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-261667", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-261667/files/kpti-20250930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -33135000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -33135000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -33135000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"diluted_average_shares": {"value": 8669, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 59264000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33127000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -33127000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "selling_general_and_administrative_expenses": {"value": 26607000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "nonoperating_income_loss": {"value": -17873000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_earnings_per_share": {"value": -3.82, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_before_tax": {"value": -33093000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 2113000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -33127000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -15220000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 8669, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "costs_and_expenses": {"value": 77137000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -3.82, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 34000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -33127000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "benefits_costs_expenses": {"value": 77137000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "revenues": {"value": 44044000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 30544000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -5860000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -5860000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": 2000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": 4805000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -1055000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 4805000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -1053000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "balance_sheet": {"inventory": {"value": 3966000.0, "unit": "USD", "label": "Inventory", "order": 230}, "fixed_assets": {"value": 122000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_receivable": {"value": 31877000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "noncurrent_liabilities": {"value": 278333000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_assets": {"value": 8003000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "liabilities": {"value": 365490000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 6486000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "cash": {"value": 45900000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 96232000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 5392000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -269258000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 96232000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 81765000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 87157000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -269258000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 89746000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 6364000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-11", "acceptance_datetime": "2025-08-11T11:34:05Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-106238", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-106238/files/kpti-20250630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 18285000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": -23340000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -23742000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": -23335000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 18285000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -18697000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": 8000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": -23734000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -18697000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"other_current_assets": {"value": 8246000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 6765000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "inventory": {"value": 4992000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 343805000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 104879000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 97870000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 7009000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 99216000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -238926000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_receivable": {"value": 32932000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_current_liabilities": {"value": 96619000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 2597000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "cash": {"value": 51700000.0, "unit": "USD", "label": "Cash", "order": 210}, "fixed_assets": {"value": 244000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 104879000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": -238926000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -37252000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 37929000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -4.32, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 8620, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": -37212000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_earnings_per_share": {"value": -4.32, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 8620, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 75141000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -37252000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 75141000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "nonoperating_income_loss": {"value": -12825000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_income_loss": {"value": -24387000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": 40000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "selling_general_and_administrative_expenses": {"value": 28477000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_parent": {"value": -37252000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 32788000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 62316000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 1051000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -37252000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -37182000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -37182000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -37182000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-12", "acceptance_datetime": "2025-05-12T20:14:43Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-069231", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-069231/files/kpti-20250331_htm.xml", "financials": {"income_statement": {"operating_income_loss": {"value": -33256000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -23462000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 36000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "nonoperating_income_loss": {"value": 9830000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_earnings_per_share": {"value": -2.77, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23462000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 34618000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_earnings_per_share": {"value": -2.77, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss": {"value": -23462000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 1301000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 8470, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 8470, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "costs_and_expenses": {"value": 53441000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "selling_general_and_administrative_expenses": {"value": 27352000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "revenues": {"value": 30015000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -23426000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -23462000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 53441000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 63271000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 23696000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 23691000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 15288000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": 5000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": -5000, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 15288000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -38984000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -10000, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -38984000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"other_noncurrent_assets": {"value": 7151000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 333595000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 5872000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": -205884000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 120238000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_assets": {"value": 10326000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_current_liabilities": {"value": 84498000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "cash": {"value": 69900000.0, "unit": "USD", "label": "Cash", "order": 210}, "assets": {"value": 127711000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 322000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_assets": {"value": 7473000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_receivable": {"value": 35243000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 90370000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "inventory": {"value": 4769000.0, "unit": "USD", "label": "Inventory", "order": 230}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -205884000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 127711000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -23427000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 35000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -23427000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-05", "acceptance_datetime": "2024-11-05T12:47:35Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-121076", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-121076/files/kpti-20240930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -11943000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -11979000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -19453000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": 36000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities_continuing": {"value": -19453000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 7474000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 7474000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"revenues": {"value": 38783000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -32072000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 28000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 36134000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 125010, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "benefits_costs_expenses": {"value": 70827000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 70827000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -32044000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -26283000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -32072000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 65066000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.26, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "selling_general_and_administrative_expenses": {"value": 27632000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "nonoperating_income_loss": {"value": -5761000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_average_shares": {"value": 125010, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "other_operating_expenses": {"value": 1300000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -32072000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -32072000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -31689000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -31689000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -31689000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"liabilities_and_equity": {"value": 189476000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_receivable": {"value": 31778000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity": {"value": -159647000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 349123000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 4721000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "inventory": {"value": 4672000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": -159647000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 287630000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 55710000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 184755000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "cash": {"value": 133500000.0, "unit": "USD", "label": "Cash", "order": 210}, "fixed_assets": {"value": 495000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_noncurrent_assets": {"value": 4226000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 189476000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 61493000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 5783000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 14805000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-06", "acceptance_datetime": "2024-08-06T11:42:02Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-091210", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-091210/files/kpti-20240630_htm.xml", "financials": {"income_statement": {"research_and_development": {"value": 38371000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": 23859000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit": {"value": 67000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": -28120000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 1465000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_earnings_per_share": {"value": -0.2, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "preferred_stock_dividends_and_other_adjustments": {"value": 5541000.0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 18927000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 70906000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 51979000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": 23792000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": 23792000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 42786000.0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 5541000.0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 121027000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "selling_general_and_administrative_expenses": {"value": 31070000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "interest_expense_operating": {"value": 8949000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": 23792000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": 0.15, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 154425000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "costs_and_expenses": {"value": 18927000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": 18251000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 51262000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 31902000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -38498000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -38498000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 19181000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": 51262000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 19165000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "exchange_gains_losses": {"value": -11000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": 31913000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"current_assets": {"value": 208540000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 213977000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_assets": {"value": 167069000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 4809000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": -132140000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 628000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": -132140000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 57619000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 213977000.0, "unit": "USD", "label": "Assets", "order": 100}, "inventory": {"value": 3476000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 346117000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 2797000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 5437000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 54822000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_receivable": {"value": 37995000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": 23705000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 23705000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": 23705000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-08", "acceptance_datetime": "2024-05-08T20:13:19Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-055672", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-055672/files/kpti-20240331_htm.xml", "financials": {"balance_sheet": {"fixed_assets": {"value": 719000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 65341000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 373413000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 6092000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "inventory": {"value": 2769000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity": {"value": -168955000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 60313000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_current_assets": {"value": 164515000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 204458000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 204458000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_receivable": {"value": 31082000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_assets": {"value": 198366000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 5373000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": -168955000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 5028000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -357000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -37719000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -37719000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -37362000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_before_tax": {"value": -37291000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -37362000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "diluted_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -33759000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 66885000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "selling_general_and_administrative_expenses": {"value": 29549000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "other_operating_expenses": {"value": 1911000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 33126000.0, "unit": "USD", "label": "Revenues", "order": 100}, "costs_and_expenses": {"value": 70417000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit": {"value": 71000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "nonoperating_income_loss": {"value": -3532000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "interest_expense_operating": {"value": 5884000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -37362000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 115454000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -37362000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.32, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 35425000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 115454000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "benefits_costs_expenses": {"value": 70417000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "cash_flow_statement": {"exchange_gains_losses": {"value": -16000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": 16000, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 21940000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 21801000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 32000, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 21940000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 21785000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -43725000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -43725000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "financials": {"cash_flow_statement": {"exchange_gains_losses": {"value": 89000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": 26843000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 8522000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 26843000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 264000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -18585000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 8611000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -18585000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 264000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "income_statement": {"operating_income_loss": {"value": -37808000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 71555000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.36, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_average_shares": {"value": 188000, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -41837000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": -3899000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_earnings_per_share": {"value": -0.36, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 130000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -41837000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -41837000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 30688000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "other_operating_expenses": {"value": 1486000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "diluted_average_shares": {"value": 188000, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "interest_expense_operating": {"value": 6208000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "costs_and_expenses": {"value": 75454000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -41837000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "benefits_costs_expenses": {"value": 75454000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 39381000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -41707000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 33747000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"other_current_assets": {"value": 203916000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_current_liabilities": {"value": 49846000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 307165000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 240438000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 233921000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_receivable": {"value": 26962000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "liabilities": {"value": 376644000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 240438000.0, "unit": "USD", "label": "Assets", "order": 100}, "wages": {"value": 16510000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 5911000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "inventory": {"value": 3043000.0, "unit": "USD", "label": "Inventory", "order": 230}, "accounts_payable": {"value": 3123000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": -136206000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": -136206000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 606000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 69479000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 6517000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 581000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -41256000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -41256000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-02", "acceptance_datetime": "2023-11-02T11:57:09Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-057754", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-057754/files/kpti-20230930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -37267000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -29530000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -7685000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -37215000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "exchange_gains_losses": {"value": -52000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": -7685000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -29530000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"costs_and_expenses": {"value": 70503000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_average_shares": {"value": 114401000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "basic_average_shares": {"value": 114401000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -34506000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 70503000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "nonoperating_income_loss": {"value": -3234000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34506000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.3, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_after_tax": {"value": -34506000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit": {"value": 12000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "interest_expense_operating": {"value": 6073000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": -34506000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 30805000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "other_operating_expenses": {"value": 911000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -34494000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 35553000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 36009000.0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_earnings_per_share": {"value": -0.3, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_expenses": {"value": 67269000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -31260000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -34465000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -34465000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -34465000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"fixed_assets": {"value": 686000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 370356000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -100396000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 62079000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 308277000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 6052000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 269960000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_assets": {"value": 222194000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "inventory": {"value": 3105000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities_and_equity": {"value": 269960000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 263222000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 61136000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_receivable": {"value": 37923000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity": {"value": -100396000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 943000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 6738000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-02", "acceptance_datetime": "2023-08-02T11:48:27Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-036780", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-036780/files/kpti-20230630_htm.xml", "financials": {"income_statement": {"nonoperating_income_loss": {"value": -2930000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 67152000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 114207000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -32630000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.29, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_tax_expense_benefit": {"value": 127000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "benefits_costs_expenses": {"value": 70082000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -32630000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_expense_operating": {"value": 5784000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "other_operating_expenses": {"value": 1194000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -32503000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "selling_general_and_administrative_expenses": {"value": 34481000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_available_to_common_stockholders_basic": {"value": -32630000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -29573000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 70082000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "research_and_development": {"value": 31477000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 37579000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.29, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "diluted_average_shares": {"value": 114207000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -32630000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -32994000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -32994000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -32994000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": -50483000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -25698000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -55082000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -55056000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -50438000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 21170000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -26000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities_continuing": {"value": -25698000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 21170000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"fixed_assets": {"value": 766000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 56641000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 6449000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_receivable": {"value": 32280000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 5683000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 369078000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": -71248000.0, "unit": "USD", "label": "Equity", "order": 1400}, "inventory": {"value": 3672000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_assets": {"value": 255429000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 291381000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 297830000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 297830000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 58928000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": -71248000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 2287000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-04", "acceptance_datetime": "2023-05-04T12:04:49Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-017483", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-017483/files/kpti-20230331_htm.xml", "financials": {"balance_sheet": {"current_assets": {"value": 318541000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": -45174000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_assets": {"value": 279514000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_assets": {"value": 7259000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 9045000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_receivable": {"value": 35200000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "liabilities_and_equity": {"value": 325800000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 6410000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 61555000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 370974000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 52510000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "inventory": {"value": 3827000.0, "unit": "USD", "label": "Inventory", "order": 230}, "fixed_assets": {"value": 849000, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": -45174000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 325800000.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 51343000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -18910000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -32388000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 90000, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 45000, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -32388000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 51298000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -18910000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": -45000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "income_statement": {"other_operating_expenses": {"value": 1351000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -34126000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "nonoperating_income_loss": {"value": -3173000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 32339000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 72770000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34126000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -30899000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 69597000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 113481000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "basic_earnings_per_share": {"value": -0.3, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_average_shares": {"value": 113481000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "interest_expense_operating": {"value": 5758000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "diluted_earnings_per_share": {"value": -0.3, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "selling_general_and_administrative_expenses": {"value": 35907000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss": {"value": -34126000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": -34072000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 72770000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_tax_expense_benefit": {"value": 54000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 38698000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -34126000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -33907000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 219000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -33907000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -65298000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 155843000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -26843000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 63702000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 63828000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -65298000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 155843000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": 126000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -26843000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "balance_sheet": {"fixed_assets": {"value": 1139000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_receivable": {"value": 47086000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "equity_attributable_to_parent": {"value": -16656000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "inventory": {"value": 4224000.0, "unit": "USD", "label": "Inventory", "order": 230}, "noncurrent_assets": {"value": 8010000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 43510000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 374828000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 65908000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 358172000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": -16656000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 19625000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_assets": {"value": 298852000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 350162000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 358172000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 308920000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 6871000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 2773000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "income_statement": {"basic_average_shares": {"value": 2718000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 1868000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -38506000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.41999999999999993, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "nonoperating_income_loss": {"value": -4564000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": -38506000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "benefits_costs_expenses": {"value": 72013000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -33869000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": 73000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -38506000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.41999999999999993, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 72013000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 5885000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "diluted_average_shares": {"value": 2718000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "revenues": {"value": 33580000.0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "selling_general_and_administrative_expenses": {"value": 34649000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "income_loss_from_continuing_operations_before_tax": {"value": -38433000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 30932000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 67449000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -38506000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -38392000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 114000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -38392000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-021917", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-021917/files/kpti-20220930_htm.xml", "financials": {"balance_sheet": {"equity": {"value": -140280000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 1252000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "prepaid_expenses": {"value": 10053000.0, "unit": "USD", "label": "Prepaid Expenses", "order": 240}, "other_noncurrent_assets": {"value": 7307000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 8559000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": -140280000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 60948000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_current_assets": {"value": 180929000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 222677000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_receivable": {"value": 27446000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 61761000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 813000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 371516000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "inventory": {"value": 4249000.0, "unit": "USD", "label": "Inventory", "order": 230}, "assets": {"value": 231236000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 231236000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 309755000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow": {"value": -10968000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -10898000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 11673000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 11673000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 5799000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -28370000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": -70000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -28370000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 5799000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -36538000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -36538000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -36538000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"operating_expenses": {"value": 66984000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_earnings_per_share": {"value": -0.45, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 36145000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 72424000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -36279000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -36324000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 31359000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 80210000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -30839000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "selling_general_and_administrative_expenses": {"value": 34645000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "diluted_average_shares": {"value": 80210000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_tax_expense_benefit": {"value": 45000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -36324000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "nonoperating_income_loss": {"value": -5440000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "costs_and_expenses": {"value": 72424000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 6114000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_available_to_common_stockholders_basic": {"value": -36324000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 980000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -36324000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "diluted_earnings_per_share": {"value": -0.45, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-04", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-014788", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-014788/files/kpti-20220630_htm.xml", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_receivable": {"value": 23479000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "liabilities_and_equity": {"value": 256478000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "prepaid_expenses": {"value": 11428000.0, "unit": "USD", "label": "Prepaid Expenses", "order": 240}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 12636000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": -116338000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 62541000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 256478000.0, "unit": "USD", "label": "Assets", "order": 100}, "inventory": {"value": 3470000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_liabilities": {"value": 60847000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 242447000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 14031000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 372816000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 1694000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 204070000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "fixed_assets": {"value": 1395000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": -116338000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"operating_expenses": {"value": 82587000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_earnings_per_share": {"value": -0.62, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "interest_expense_operating": {"value": 6313000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "selling_general_and_administrative_expenses": {"value": 37339000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_attributable_to_parent": {"value": -49062000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 79651000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -48941000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_earnings_per_share": {"value": -0.62, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "nonoperating_income_loss": {"value": -6033000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 39679000.0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 79651000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "costs_and_expenses": {"value": 88620000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -42908000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 44309000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 939000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 88620000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": -49062000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": 121000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -49062000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -49062000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -70427000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -70881000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -35144000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 1313000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 1313000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": -454000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities": {"value": -36596000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -36596000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -35144000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -49687000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -49687000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -49687000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-05", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-007564", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-007564/files/kpti-20220331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -42539000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -14035000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 30783000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -59197000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -14035000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 30783000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -42449000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -59197000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": -90000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}}, "balance_sheet": {"other_current_liabilities": {"value": 62897000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 15956000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 294033000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_receivable": {"value": 24992000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "liabilities": {"value": 377112000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "prepaid_expenses": {"value": 12207000.0, "unit": "USD", "label": "Prepaid Expenses", "order": 240}, "inventory": {"value": 3874000.0, "unit": "USD", "label": "Inventory", "order": 230}, "fixed_assets": {"value": 1544000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 276533000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": -83079000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 17500000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 235460000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "assets": {"value": 294033000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 66337000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": -83079000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "accounts_payable": {"value": 3440000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "income_statement": {"selling_general_and_administrative_expenses": {"value": 38768000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "income_tax_expense_benefit": {"value": 130000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -41399000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 88939000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 88939000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": -0.5299999999999999, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "research_and_development": {"value": 42062000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -41399000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": -6683000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 47670000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.5299999999999999, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 1426000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -41399000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": -1035000.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": -1035000.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -41269000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 82256000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -41399000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -34586000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_expense_operating": {"value": 6684000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -41503000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -41503000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -104000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": 57006000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 30770000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 30770000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 57141000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 896000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": 25475000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": 25475000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": -135000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities_continuing": {"value": 896000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "income_statement": {"revenues": {"value": 126269000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 87670000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": 46962000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "nonoperating_income_loss": {"value": -8363000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 79307000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_before_tax": {"value": 38599000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": 38720000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "selling_general_and_administrative_expenses": {"value": 34562000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "costs_and_expenses": {"value": 87670000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": 38720000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": 38720000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 44003000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "interest_expense_operating": {"value": 7940000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": 38720000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 742000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": -121000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}, "balance_sheet": {"other_noncurrent_assets": {"value": 28057000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": -79673000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 52428000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 275606000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "long_term_debt": {"value": 169293000.0, "unit": "USD", "label": "Long-term Debt", "order": 810}, "inventory": {"value": 4106000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity": {"value": -79673000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 29699000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 249003000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_receivable": {"value": 22497000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 73718000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "wages": {"value": 19687000.0, "unit": "USD", "label": "Wages", "order": 730}, "assets": {"value": 305305000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 1642000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 305305000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "accounts_payable": {"value": 1603000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_liabilities": {"value": 141967000.0, "unit": "USD", "label": "Other Non-current Liabilities", "order": 820}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 311260000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 384978000.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": 38539000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": 38539000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -181000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-03", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-002729", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-002729/files/kpti-20210930_htm.xml", "financials": {"balance_sheet": {"inventory": {"value": 3943000.0, "unit": "USD", "label": "Inventory", "order": 230}, "liabilities": {"value": 380071000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_assets": {"value": 218884000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_assets": {"value": 12515000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 10941000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": -125977000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": -125977000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 311205000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_current_liabilities": {"value": 67985000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 241579000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 254094000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 1574000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_receivable": {"value": 18752000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_liabilities": {"value": 68866000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 881000, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 254094000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"research_and_development": {"value": 45808000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -51706000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "selling_general_and_administrative_expenses": {"value": 35104000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 37689000.0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": -7894000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "interest_expense_operating": {"value": 8010000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_income_loss": {"value": -43812000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -51812000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -51812000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 89395000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -51812000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 81501000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": 106000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -51812000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 589000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 89395000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -51636000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -51636000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -51636000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -23955000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -2513000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 16000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -23955000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": 242000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": 21426000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 16000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -2271000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 21426000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-05", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-000948", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-000948/files/kpti-20210630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -55748000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 52706000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 52770000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 62060000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -55748000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "exchange_gains_losses": {"value": -64000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities": {"value": 46458000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": 46458000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 62060000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -53687000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -53687000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -53687000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -53582000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 76049000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 71649000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 33981000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -53448000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 1138000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "interest_expense_operating": {"value": 5001000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss": {"value": -53582000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -53582000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "nonoperating_income_loss": {"value": -4400000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "selling_general_and_administrative_expenses": {"value": 36530000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "net_income_loss_available_to_common_stockholders_basic": {"value": -53582000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -49048000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit": {"value": 134000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "costs_and_expenses": {"value": 76049000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "revenues": {"value": 22601000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "balance_sheet": {"current_assets": {"value": 273502000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": -83132000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 286567000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 58123000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 1755000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities": {"value": 369699000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 2309000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 55814000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_receivable": {"value": 17887000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 11310000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 286567000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_assets": {"value": 251710000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "inventory": {"value": 3905000.0, "unit": "USD", "label": "Inventory", "order": 230}, "noncurrent_assets": {"value": 13065000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": -83132000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-04", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-000073", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-000073/files/kpti-20210331_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -57631000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -57631000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -217000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 5095000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "benefits_costs_expenses": {"value": 80525000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 37050000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -57414000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "selling_general_and_administrative_expenses": {"value": 37650000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_income_loss": {"value": -52373000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -57414000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "nonoperating_income_loss": {"value": -4892000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -57265000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 80525000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 933000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": 149000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -57414000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 75633000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 23260000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -57414000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 974000, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 43186000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 10676000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "exchange_gains_losses": {"value": -91000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities": {"value": -52888000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 883000, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 10676000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 43186000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -52888000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"equity_attributable_to_parent": {"value": -39640000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": -39640000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 1984000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 274909000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 19398000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 58968000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_receivable": {"value": 17843000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "other_noncurrent_assets": {"value": 17414000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "inventory": {"value": 3114000.0, "unit": "USD", "label": "Inventory", "order": 230}, "other_current_assets": {"value": 234554000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "accounts_payable": {"value": 3040000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 274909000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 62008000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 255511000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 314549000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 31397000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -30634000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 31397000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 3968000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -30634000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": 283000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": 4731000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 3968000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 5014000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "income_statement": {"revenues": {"value": 35100000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -43421000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 78459000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_expense_operating": {"value": 7072000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -43421000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_before_tax": {"value": -43359000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 78459000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -37066000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": 62000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 72166000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "nonoperating_income_loss": {"value": -6293000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -43421000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 1767000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 37185000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -43421000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "selling_general_and_administrative_expenses": {"value": 33929000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}}, "balance_sheet": {"accounts_payable": {"value": 4450000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 313050000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 262504000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 202301000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 50546000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_current_liabilities": {"value": 39539000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 34300000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_assets": {"value": 36519000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_assets": {"value": 261006000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity": {"value": 50546000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_receivable": {"value": 12881000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "current_assets": {"value": 276531000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "wages": {"value": 16214000.0, "unit": "USD", "label": "Wages", "order": 730}, "inventory": {"value": 2644000.0, "unit": "USD", "label": "Inventory", "order": 230}, "current_liabilities": {"value": 60203000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 313050000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 2219000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -43506000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -43506000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -85000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2020-07-01", "end_date": "2020-09-30", "filing_date": "2020-11-02", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2020", "cik": "0001503802", "sic": "2834", "tickers": ["KPTI"], "company_name": "Karyopharm Therapeutics Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-20-049664", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-20-049664/files/kpti-10q_20200930_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -44312000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 21431000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": 17000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": 21431000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -21624000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -44312000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1240000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 1240000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -21641000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -53783000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -53783000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -53783000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "income_statement": {"net_income_loss": {"value": -53495000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "depreciation_and_amortization": {"value": 235000, "unit": "USD", "label": "Depreciation and Amortization", "order": 1020}, "selling_general_and_administrative_expenses": {"value": 30967000.0, "unit": "USD", "label": "Selling, General, and Administrative Expenses", "order": 1010}, "operating_income_loss": {"value": -47109000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -53495000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 44000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 21333000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 74784000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_expense_operating": {"value": 6801000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "nonoperating_income_loss": {"value": -6342000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_before_tax": {"value": -53451000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 68442000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -53495000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 37037000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -53495000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 74784000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 438000, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "balance_sheet": {"current_liabilities": {"value": 52630000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 50208000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 253817000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 2422000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "fixed_assets": {"value": 2357000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "inventory": {"value": 2011000.0, "unit": "USD", "label": "Inventory", "order": 230}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_receivable": {"value": 11062000.0, "unit": "USD", "label": "Accounts Receivable", "order": 220}, "assets": {"value": 337587000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 337587000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 201187000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 52140000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 49783000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "other_current_assets": {"value": 272374000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_assets": {"value": 285447000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 83770000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 83770000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}]